{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T19:10:35Z","timestamp":1793214635788,"version":"4.5.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,3,5]],"date-time":"2018-03-05T00:00:00Z","timestamp":1520208000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology Case Reports"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.ajoc.2018.03.005","type":"journal-article","created":{"date-parts":[[2018,3,8]],"date-time":"2018-03-08T02:29:00Z","timestamp":1520476140000},"page":"203-205","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Topical interferon alpha 2b in the treatment of refractory pseudophakic cystoid macular edema"],"prefix":"10.1016","volume":"10","author":[{"given":"Arash","family":"Maleki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Aghaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ajoc.2018.03.005_bib1","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jcrs.2016.06.041","article-title":"Treatment of cystoid macular edema after cataract surgery","volume":"43","author":"Wielders","year":"2017","journal-title":"J Cataract Refract Surg"},{"issue":"1","key":"10.1016\/j.ajoc.2018.03.005_bib2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/IAE.0b013e3181fd9740","article-title":"Pharmacologic therapy of pseudophakic cystoid macular edema; 2010 update","volume":"31","author":"Shelsta","year":"2011","journal-title":"Retina"},{"issue":"3","key":"10.1016\/j.ajoc.2018.03.005_bib3","first-page":"235","article-title":"Intravitreal bevacizumab for pseudophakic cystoid macular edema; a systematic review","volume":"7","author":"Falavarjani","year":"2012","journal-title":"J Ophthalmic Vis Res"},{"issue":"11","key":"10.1016\/j.ajoc.2018.03.005_bib4","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1016\/S0161-6420(00)00365-1","article-title":"Ketorolac versus prednisolone versus combination therapy in the treatment of acute pseudophakic cystoid macular edema","volume":"107","author":"Heier","year":"2000","journal-title":"Ophthalmology"},{"issue":"suppl 1","key":"10.1016\/j.ajoc.2018.03.005_bib5","first-page":"103","article-title":"Treatment of pseudophakic cystoid macular oedema","volume":"29","author":"Curkovi","year":"2005","journal-title":"Coll Antropol"},{"issue":"3","key":"10.1016\/j.ajoc.2018.03.005_bib6","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3109\/09273948.2011.562341","article-title":"Successful treatment of chronic pseudophakic macular edema (Irvine-Gass syndrome) with interferon alpha: a report of three cases","volume":"19","author":"Deuter","year":"2011","journal-title":"Ocul Immunol Inflamm"},{"issue":"5","key":"10.1016\/j.ajoc.2018.03.005_bib7","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/APO.0000000000000104","article-title":"Topical interferon \u03b1-2b as a single therapy for primary ocular surface squamous neoplasia","volume":"4","author":"Kusumesh","year":"2015","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"issue":"1","key":"10.1016\/j.ajoc.2018.03.005_bib8","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.pharmthera.2012.03.006","article-title":"Pharmacology and therapeutic potential of interferons","volume":"135","author":"George","year":"2012","journal-title":"Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.ajoc.2018.03.005_bib9","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1006\/mvre.1995.1024","article-title":"Interferon-alpha 2b enhances barrier function of bovine retinal microvascular endothelium in vitro","volume":"49","author":"Gillies","year":"1995","journal-title":"Microvasc Res"},{"issue":"13","key":"10.1016\/j.ajoc.2018.03.005_bib10","first-page":"2768","article-title":"Choroidal concentration of interferon after retrobulbar injection","volume":"37","author":"Lincoff","year":"1996","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.ajoc.2018.03.005_bib11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ajo.2007.03.050","article-title":"Interferon- \u03b1 as an effective treatment for noninfectious posterior uveitis and panuveitis","volume":"144","author":"Plskova","year":"2007","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajoc.2018.03.005_bib12","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.semarthrit.2003.09.010","article-title":"The use of interferon \u03b1 in Beh\u00e7et disease: review of the literature","volume":"33","author":"K\u00f6tter","year":"2004","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.ajoc.2018.03.005_bib13","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s10384-005-0307-8","article-title":"Neovascularization of the optic disc in Beh\u00e7et's disease","volume":"50","author":"Tugal- Tutkun","year":"2006","journal-title":"Jpn J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajoc.2018.03.005_bib14","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1136\/bjo.2006.101550","article-title":"Efficacy of interferon alpha in the treatment of refractory and sight threatening uveitis: a retrospective monocentric study of 45 patients","volume":"91","author":"Bodaghi","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajoc.2018.03.005_bib15","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2415-13-63","article-title":"Subtenon injection of natural leukocyte interferon \u03b1-2a in diabetic macular edema: a case report","volume":"13","author":"Cellini","year":"2013","journal-title":"BMC Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajoc.2018.03.005_bib16","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jfo.2010.01.008","article-title":"Effectiveness of interferon alpha in the treatment of uveitis macular edema refractory to corticosteroid and\/or immunosuppressive treatment","volume":"33","author":"Paire","year":"2010","journal-title":"J Fr Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajoc.2018.03.005_bib17","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3109\/09273948.2011.645989","article-title":"Interferon alpha 2b in the treatment of uveitic cystoid macular edema","volume":"20","author":"Butler","year":"2012","journal-title":"Ocul Immunol Inflamm"},{"issue":"9","key":"10.1016\/j.ajoc.2018.03.005_bib18","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.oftal.2017.01.013","article-title":"Topical interferon alpha-2B topic as the first therapeutic option in a clinical case of conjunctival intraepithelial neoplasia","volume":"92","author":"Pag\u00e1n Carrasco","year":"2017","journal-title":"Arch Soc Esp Oftalmol"},{"issue":"11","key":"10.1016\/j.ajoc.2018.03.005_bib19","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1007\/s00417-017-3754-2","article-title":"Long-term follow-up of conjunctival melanoma treated with topical interferon alpha-2b eye drops as adjunctive therapy following surgical resection","volume":"255","author":"Kikuchi","year":"2017","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"10","key":"10.1016\/j.ajoc.2018.03.005_bib20","doi-asserted-by":"crossref","first-page":"778","DOI":"10.4103\/0301-4738.195013","article-title":"Interferon alfa-2b in the management of recurrent conjunctival papillomatosis","volume":"64","author":"Singh","year":"2016","journal-title":"Indian J Ophthalmol"}],"container-title":["American Journal of Ophthalmology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993617303328?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993617303328?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T14:57:47Z","timestamp":1762527467000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451993617303328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":20,"alternative-id":["S2451993617303328"],"URL":"https:\/\/doi.org\/10.1016\/j.ajoc.2018.03.005","relation":{},"ISSN":["2451-9936"],"issn-type":[{"value":"2451-9936","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Topical interferon alpha 2b in the treatment of refractory pseudophakic cystoid macular edema","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajoc.2018.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}